NewsResearches Develop Mutant Gene-Targeted ImmunotherapyJohns Hopkins Medicine | March 2, 2021 The novel immunotherapy approach uses bispecific antibodies against mutant proteins to target cancer cells
NewsCombined Neoadjuvant Immunotherapy Improves NSCLC OutcomesUniversity of Texas MD Anderson Cancer Center | February 18, 2021 This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC
NewsInsight about Tumor Microenvironment Could Boost Cancer ImmunotherapyUniversity of Pittsburgh | February 16, 2021 Study shows how chemicals in the tumor microenvironment subvert the immune system, enabling cancer to evade attack
NewsStudy Examines Role of Biomarkers to Evaluate Kidney Injury in Cancer PatientsMayo Clinic | February 5, 2021 The biomarkers could help discriminate treatment-associated kidney injury from other causes, guiding treatment
Thought LeadershipSponsoredHow Precision-Controlled Environments Support Clinical Cell CultureErica Tennenhouse, PhD | February 2, 2021 As cell culture has gained more importance in research, it has evolved—and the incubator has evolved along with it
NewsLearning How Cancer Cells Evade Immune Defenses Inspires New Treatment ApproachMemorial Sloan Kettering Cancer Center | December 29, 2020 The results help explain why some tumors do not respond to immunotherapy and suggest ways to improve it
NewsImmune Cell That Drives Breast Cancer Could Be Effective Immunotherapy TargetVirginia Commonwealth University | December 16, 2020 New research identified a type of immune cell that promotes breast cancer growth by preventing anti-tumor responses
NewsResearchers Identify Genomic Indicators That Predict Prostate Cancer OutcomesH. Lee Moffitt Cancer Center & Research Institute | December 15, 2020 Genomic heterogeneity in tumors can also be exploited to identify patient subsets that may benefit from targeted treatment strategies
NewsNew Immunotherapy Shows Promise Against Rare Childhood CancerUniversity College London | November 30, 2020 The study is one of the first to demonstrate CAR T-cells achieving rapid regression against a solid cancer
NewsNew Diagnostic Method Predicts Who Will Respond to ImmunotherapyUniversity of the Basque Country | November 19, 2020 The new advanced microscopy platform can identify the immune checkpoints that buffer the anti-tumor response